Daiwa Securities Group Inc. Ionis Pharmaceuticals Inc Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 541 shares of IONS stock, worth $20,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
541
Previous 541
-0.0%
Holding current value
$20,141
Previous $26,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
136MCall Options Held
882KPut Options Held
476K-
Vanguard Group Inc Valley Forge, PA15.1MShares$561 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$527 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$384 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$325 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$293 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.28B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...